|
Regulation
Citations 1-10 of 216 total displayed.
|
Most recent content
(15 Jun 2010):
|
- News
Pan-Canadian review of cancer drugs will not be binding on provinces
- Lauren Vogel
Can. Med. Assoc. J. 2010; 182: 887-888.
[Full text]
[PDF]
|
Past content
(since Jul 1999):
|
- Analysis
Tough choices: private sale of drugs in public hospitals
- Colleen M. Flood and Lorian Hardcastle
Can. Med. Assoc. J. 2010; 182: 374-376.
[Full text]
[PDF]
- News
China’s counterfeit medicine trade booming
- Katie Lewis
Can. Med. Assoc. J. 2009; 181: E237-238E.
[Full text]
[PDF]
- News
Enzyme therapy for Fabry patients in jeopardy
- Ann Silversides
Can. Med. Assoc. J. 2009; 181: E120.
[Full text]
[PDF]
- News
Fabry trial set to answer "political problem"
- Ann Silversides
Can. Med. Assoc. J. 2009; 181: 365-366.
[Full text]
[PDF]
- News
Charter challenge of ban on direct-to-consumer advertising to be heard by Ontario court in mid-June
- Ann Silversides
Can. Med. Assoc. J. 2009; 181: E5-6E.
[Full text]
[PDF]
- News
Clinical trials: the balance between protecting participants and promoting drug and product development
- Miriam Shuchman
Can. Med. Assoc. J. 2009; 180: 603-606.
[Full text]
[PDF]
- News
Clinical trial participation poses ethical, practical issues
- Ann Silversides
Can. Med. Assoc. J. 2009; 180: 500-502.
[Full text]
[PDF]
- News
Clinical trials: chasing recruits
- Ann Silversides
Can. Med. Assoc. J. 2009; 180: 375-378.
[Full text]
[PDF]
- News
Antismoking drug still recommended to Canadians despite side effects and US advisory
- Roger Collier
Can. Med. Assoc. J. 2009; 180: 381.
[Full text]
[PDF]
|
|
